New drug combo aims to reboot cancer treatment for tough cases

NCT ID NCT04219254

Recruiting now Disease control Sponsor: BioInvent International AB Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug, BI-1206, given alongside the immunotherapy pembrolizumab. It aims to see if this combination is safe and can help control advanced solid tumors, particularly in adults with non-small cell lung cancer or uveal melanoma who have not responded well to previous treatments. The trial is currently enrolling participants to find the best dose and look for early signs of effectiveness.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centrul de Oncologie SF Nectarie SRL
RECRUITING

Craiova, Romania

Contact
Clinica Universidad de Navarra
NOT_YET_RECRUITING

Pamplona, Spain

Contact
HealthPartners Institute - Regions Cancer Care Center,
COMPLETED

Saint Paul, Minnesota, 55101, United States
Hospital Puerta de Hierro
NOT_YET_RECRUITING

Majadahonda, Spain

Contact
Hospital Universitari Dexeus
RECRUITING

Barcelona, Spain

Contact
Hospital Universitari Vall D´Hebron
NOT_YET_RECRUITING

Barcelona, Spain

Contact
Hospital Virgen de la Macarena
RECRUITING

Seville, Spain

Contact
Institut Català d'Oncologia Hospital Duran i Reynals
NOT_YET_RECRUITING

Barcelona, Spain

Contact
Institutul Oncologic "Prof. Dr. Ion Chiricuta"
RECRUITING

Cluj-Napoca, Romania

Contact
Instytut Centrum Zdrowia Matki Polki
RECRUITING

Lodz, Poland

Contact
Israel-Georgian Medical Research Clinic Helsicore
NOT_YET_RECRUITING

Tbilisi, Georgia

Contact
Jerarsi Clinic
RECRUITING

Tbilisi, Georgia

Contact
Karolinska University Hospital, Solna
RECRUITING

Stockholm, Sweden

Contact
LTD High Technology Hospital Med Center
RECRUITING

Batumi, Georgia

Contact
Lund University Hospital
RECRUITING

Lund, Sweden

Contact
Maria Skłodowska-Curie National Institute of Oncology
NOT_YET_RECRUITING

Gliwice, Poland

Contact
Medical University of Silesia
NOT_YET_RECRUITING

Katowice, Poland

Contact
Medizinische Hochschule Hannover
NOT_YET_RECRUITING

Hanover, Germany

Contact
NEXT Oncology
COMPLETED

San Antonio, Texas, 78229, United States
Nationales Centrum für Tumorerkrankungen
NOT_YET_RECRUITING

Heidelberg, Germany

Contact
Oklahoma University , Stephenson Cancer Center
COMPLETED

Oklahoma City, Oklahoma, 73104, United States
Sahlgrenska University Hospital
COMPLETED

Gothenburg, Sweden
Sarah Cannon Research Institute
COMPLETED

Denver, Colorado, 80218, United States
University of California Los Angeles
NOT_YET_RECRUITING

Los Angeles, California, 90024, United States

Contact
Universität des Saarlandes
NOT_YET_RECRUITING

Homburg, Germany

Contact

Conditions

Explore the condition pages connected to this study.

SOLID TUMOR, ADULT